The Emerging Role of Ferroptosis in Various Chronic Liver Diseases: Opportunity or Challenge

References

• Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130–143. doi:10.1016/j.freeradbiomed.2018.09.043
   PubMed Web of Science ®Google Scholar
• Finn AV, Nakano M, Polavarapu R, et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol. 2012;59(2):166–177. doi:10.1016/j.jacc.2011.10.852
   PubMed Web of Science ®Google Scholar
• Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database. 2020;2020. doi:10.1093/database/baaa021
   Google Scholar
• Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107–125. doi:10.1038/s41422-020-00441-1
   PubMed Web of Science ®Google Scholar
• Battaglia AM, Chirillo R, Aversa I, Sacco A, Costanzo F, Biamonte F. Ferroptosis and cancer: mitochondria meet the “iron maiden” cell death. Cells. 2020;9(6):1505. doi:10.3390/cells9061505
   PubMed Web of Science ®Google Scholar
• Kose T, Vera-Aviles M, Sharp PA, Latunde-Dada GO. Curcumin and (-)- epigallocatechin-3-gallate protect murine MIN6 pancreatic beta-cells against iron toxicity and erastin-induced ferroptosis. Pharmaceuticals. 2019;12(1). doi:10.3390/ph12010026
   Web of Science ®Google Scholar
• Song X, Xie Y, Kang R, et al. FANCD2 protects against bone marrow injury from ferroptosis. Biochem Biophys Res Commun. 2016;480(3):443–449. doi:10.1016/j.bbrc.2016.10.068
   PubMed Web of Science ®Google Scholar
• Wang W, Green M, Choi JE, et al. CD8 T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270–274. doi:10.1038/s41586-019-1170-y
   PubMed Web of Science ®Google Scholar
• Tang HM, Tang HL. Cell recovery by reversal of ferroptosis. Biol Open. 2019;8(6). doi:10.1242/bio.043182
   Web of Science ®Google Scholar
• Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054–2081. doi:10.1080/15548627.2020.1810918
   PubMed Web of Science ®Google Scholar
• Wu J, Eckard J, Chen H, Costa M, Frenkel K, Huang X. Altered iron homeostasis involvement in arsenite-mediated cell transformation. Free Radic Biol Med. 2006;40(3):444–452. doi:10.1016/j.freeradbiomed.2005.08.035
   Web of Science ®Google Scholar
• Canli Ã, Alankuåÿ YB, Grootjans S, et al. Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood. 2016;127(1):139–148. doi:10.1182/blood-2015-06-654194
   PubMed Web of Science ®Google Scholar
• Pimpin L, Cortez-Pinto H, Negro F, et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718–735. doi:10.1016/j.jhep.2018.05.011
   PubMed Web of Science ®Google Scholar
• Gao W, Zhao J, Gao Z, Li H. Synergistic interaction of light alcohol administration in the presence of mild iron overload in a mouse model of liver injury: involvement of triosephosphate isomerase nitration and inactivation. PLoS One. 2017;12(1):e0170350. doi:10.1371/journal.pone.0170350
   Web of Science ®Google Scholar
• Qi J, Kim J-W, Zhou Z, Lim C-W, Kim B. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice. Am J Pathol. 2020;190(1):68–81. doi:10.1016/j.ajpath.2019.09.011
   PubMed Web of Science ®Google Scholar
• Yamane D, Hayashi Y, Matsumoto M, et al. FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication. Cell Chem Biol. 2022;29(5):799–810.e4. doi:10.1016/j.chembiol.2021.07.022
   PubMed Web of Science ®Google Scholar
• Wang R, Zhao S, Du J, Qiao J, Li W, Nan Y. A correlation analysis of the serum hepcidin concentrations and viral loads in HCV-infected patients. Am J Transl Res. 2021;13(6):6297–6304.
   Web of Science ®Google Scholar
• Chang M-L, Hu J-H, Yen C-H, et al. Evolution of ferritin levels in hepatitis C patients treated with antivirals. Sci Rep. 2020;10(1):19744. doi:10.1038/s41598-020-76871-z
   Web of Science ®Google Scholar
• Bian Z, Hann H-W, Ye Z, et al. Ferritin level prospectively predicts hepatocarcinogenesis in patients with chronic hepatitis B virus infection. Oncol Lett. 2018;16(3):3499–3508. doi:10.3892/ol.2018.9099
   PubMed Web of Science ®Google Scholar
• Luo J, Liang X, Xin J, et al. Serum ferritin diagnosis and prediction of hepatitis B virus-related acute-on-chronic liver failure. J Med Virol. 2022;95:e28183.
   Web of Science ®Google Scholar
• Komissarov AA, Karaseva MA, Roschina MP, et al. Individual expression of hepatitis A virus 3C protease induces ferroptosis in human cells in vitro. Int J Mol Sci. 2021;22(15):7906. doi:10.3390/ijms22157906
   PubMed Web of Science ®Google Scholar
• Dimitriadis A, Foka P, Kyratzopoulou E, et al. The Hepatitis C virus NS5A and core proteins exert antagonistic effects on HAMP gene expression: the hidden interplay with the MTF-1/MRE pathway. FEBS Open Bio. 2021;11(1):237–250. doi:10.1002/2211-5463.13048
   Web of Science ®Google Scholar
• Foka P, Dimitriadis A, Karamichali E, et al. HCV-induced immunometabolic crosstalk in a triple-cell co-culture model capable of simulating systemic iron homeostasis. Cells. 2021;10(9):2251. doi:10.3390/cells10092251
   Web of Science ®Google Scholar
• Haberger V, Elgner F, Roos J, Bender D, Hildt E. Regulation of the transferrin receptor recycling in hepatitis C virus-replicating cells. Front Cell Dev Biol. 2020;8:44. doi:10.3389/fcell.2020.00044
   Web of Science ®Google Scholar
• Liu G-Z, Xu X-W, Tao S-H, Gao M-J, Hou Z-H. HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression. J Biomed Sci. 2021;28(1):67. doi:10.1186/s12929-021-00762-2
   PubMed Web of Science ®Google Scholar
• Ma S, Liu A, Hu X, et al. Eltrombopag inhibits Type I interferon-mediated antiviral signaling by decreasing cellular iron. Biochem Pharmacol. 2021;186:114436. doi:10.1016/j.bcp.2021.114436
   Web of Science ®Google Scholar
• Xing G, Meng L, Cao S, et al. PPARα alleviates iron overload-induced ferroptosis in mouse liver. EMBO Rep. 2022;23(8):e52280. doi:10.15252/embr.202052280
   Web of Science ®Google Scholar
• Bessone F, Lucena MI, Roma MG, et al. Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases. Liver Int. 2016;36(2):302–310. doi:10.1111/liv.12899
   PubMed Web of Science ®Google Scholar
• Imaizumi N, Kwang Lee K, Zhang C, Boelsterli UA. Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I. Redox Biol. 2015;4:279–288. doi:10.1016/j.redox.2015.01.005
   PubMed Web of Science ®Google Scholar
• Zhou J, Tan Y, Hu L, et al. Inhibition of HSPA8 by rifampicin contributes to ferroptosis via enhancing autophagy. Liver Int. 2022;42(12):2889–2899. doi:10.1111/liv.15459
   PubMed Web of Science ®Google Scholar
• Pan Y, Tang P, Cao J, et al. Lipid peroxidation aggravates anti-tuberculosis drug-induced liver injury: evidence of ferroptosis induction. Biochem Biophys Res Commun. 2020;533(4):1512–1518. doi:10.1016/j.bbrc.2020.09.140
   Web of Science ®Google Scholar
• Yang L, Wang H, Yang X, et al. Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms. Signal Transduct Target Ther. 2020;5(1):138. doi:10.1038/s41392-020-00253-0
   PubMed Web of Science ®Google Scholar
• Niu B, Lei X, Xu Q, et al. Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in Acetaminophen-induced acute liver injury. Cell Biol Toxicol. 2022;38(3):505–530. doi:10.1007/s10565-021-09624-x
   PubMed Web of Science ®Google Scholar
• Wu L, Ding Q, Wang X, et al. Visualization of dynamic changes in labile iron(II) pools in endoplasmic reticulum stress-mediated drug-induced liver injury. Anal Chem. 2020;92(1):1245–1251. doi:10.1021/acs.analchem.9b04411
   Web of Science ®Google Scholar
• Martin SR, Alvarez F, Anand R, Song C, Yin W. Outcomes in children who underwent transplantation for autoimmune hepatitis. Liver Transpl. 2011;17(4):393–401. doi:10.1002/lt.22244
   Web of Science ®Google Scholar
• Suzuki Y, Saito H, Suzuki M, et al. Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res. 2002;26(8Suppl):26S–31S. doi:10.1111/j.1530-0277.2002.tb02698.x
   Google Scholar
• Dostalikova-Cimburova M, Balusikova K, Kratka K, et al. Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease. J Cell Mol Med. 2014;18(9):1840–1850. doi:10.1111/jcmm.12310
   PubMed Web of Science ®Google Scholar
• Li L-X, Guo -F-F, Liu H, Zeng T. Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets. Cell Mol Life Sci. 2022;79(4):201. doi:10.1007/s00018-022-04239-9
   PubMed Web of Science ®Google Scholar
• Liu J, He H, Wang J, et al. Oxidative stress-dependent frataxin inhibition mediated alcoholic hepatocytotoxicity through ferroptosis. Toxicology. 2020;445:152584. doi:10.1016/j.tox.2020.152584
   Web of Science ®Google Scholar
• Zhang Y, Zhao S, Fu Y, et al. Computational repositioning of dimethyl fumarate for treating alcoholic liver disease. Cell Death Dis. 2020;11(8):641. doi:10.1038/s41419-020-02890-3
   PubMed Web of Science ®Google Scholar
• Xu M-J, Cai Y, Wang H, et al. Fat-specific protein 27/CIDEC promotes development of alcoholic steatohepatitis in mice and humans. Gastroenterology. 2015;149(4):1030–1041.e6. doi:10.1053/j.gastro.2015.06.009
   Web of Science ®Google Scholar
• Zhou Z, Ye TJ, Bonavita G, et al. Adipose-specific lipin-1 overexpression renders hepatic ferroptosis and exacerbates alcoholic steatohepatitis in mice. Hepatol Commun. 2019;3(5):656–669. doi:10.1002/hep4.1333
   PubMed Web of Science ®Google Scholar
• You Y, Liu C, Liu T, et al. FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease. Free Radic Biol Med. 2022;193:808–819. doi:10.1016/j.freeradbiomed.2022.10.322
   Web of Science ®Google Scholar
• Ma C, Han L, Zhu Z, Heng Pang C, Pan G. Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases. Biochem Pharmacol. 2022;205:115242. doi:10.1016/j.bcp.2022.115242
   Web of Science ®Google Scholar
• Wang S, Liu Z, Geng J, Li L, Feng X. An overview of ferroptosis in non-alcoholic fatty liver disease. Biomed Pharmacother. 2022;153:113374. doi:10.1016/j.biopha.2022.113374
   PubMed Web of Science ®Google Scholar
• Feng G, Byrne CD, Targher G, Wang F, Zheng M-H. Ferroptosis and metabolic dysfunction-associated fatty liver disease: is there a link? Liver Int. 2022;42(7):1496–1502. doi:10.1111/liv.15163
   Web of Science ®Google Scholar
• Eder SK, Feldman A, Strebinger G, et al. Mesenchymal iron deposition is associated with adverse long-term outcome in non-alcoholic fatty liver disease. Liver Int. 2020;40(8):1872–1882. doi:10.1111/liv.14503
   Web of Science ®Google Scholar
• Tsurusaki S, Tsuchiya Y, Koumura T, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 2019;10(6):449. doi:10.1038/s41419-019-1678-y
   PubMed Web of Science ®Google Scholar
• Pan X, Peng H, Zhang J, Wu Y, Hu Z, Peng X-E. Genetic variants in promoter region of is associated with the risk of non-alcoholic fatty liver disease in a Chinese Han population: a case-control study. Gastroenterol Rep. 2022;10:goac060. doi:10.1093/gastro/goac060
   Google Scholar
• Liu S, Gao Z, He W, et al. The gut microbiota metabolite glycochenodeoxycholate activates TFR-ACSL4-mediated ferroptosis to promote the development of environmental toxin-linked MAFLD. Free Radic Biol Med. 2022;193(Pt 1):213–226. doi:10.1016/j.freeradbiomed.2022.10.270
   Google Scholar
• Yao C, Lan D, Li X, Wang Y, Qi S, Liu Y. Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis. Microbes Infect. 2022;25:105040. doi:10.1016/j.micinf.2022.105040
   Web of Science ®Google Scholar
• Montano-Loza AJ, Ronca V, Ebadi M, et al. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. J Hepatol. 2022;77(1):84–97. doi:10.1016/j.jhep.2022.01.022
   Web of Science ®Google Scholar
• Hajoui O, Martin S, Alvarez F. Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies. Clin Exp Immunol. 1998;113(3):339–345. doi:10.1046/j.1365-2249.1998.00673.x
   Web of Science ®Google Scholar
• Liu Y, Chen H, Hao J, Li Z, Hou T, Hao H. Characterization and functional prediction of the microRNAs differentially expressed in a mouse model of concanavalin A-induced autoimmune hepatitis. Int J Med Sci. 2020;17(15):2312–2327. doi:10.7150/ijms.47766
   Web of Science ®Google Scholar
• Zhu L, Chen D, Zhu Y, et al. GPX4-regulated ferroptosis mediates S100-induced experimental autoimmune hepatitis associated with the Nrf2/HO-1 signaling pathway. Oxid Med Cell Longev. 2021;2021:6551069. doi:10.1155/2021/6551069
   PubMed Web of Science ®Google Scholar
• Zeng T, Deng G, Zhong W, et al. Indoleamine 2, 3-dioxygenase 1enhanceshepatocytes ferroptosis in acute immune hepatitis associated with excess nitrative stress. Free Radic Biol Med. 2020;152:668–679. doi:10.1016/j.freeradbiomed.2020.01.009
   PubMed Web of Science ®Google Scholar
• Selmi C, Generali E, Gershwin ME. Rheumatic manifestations in autoimmune liver disease. Rheum Dis Clin North Am. 2018;44(1):65–87. doi:10.1016/j.rdc.2017.09.008
   Web of Science ®Google Scholar
• Deng G, Li Y, Ma S, et al. Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress. Free Radic Biol Med. 2020;148:151–161. doi:10.1016/j.freeradbiomed.2019.12.026
   PubMed Web of Science ®Google Scholar
• Gracia-Sancho J, Casillas-RamÃ-rez A, Peralta C. Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update. Clin Sci. 2015;129(4):345–362. doi:10.1042/CS20150223
   PubMed Web of Science ®Google Scholar
• Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180–1191. doi:10.1038/ncb3064
   PubMed Web of Science ®Google Scholar
• Yamada N, Karasawa T, Wakiya T, et al. Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: potential role of ferroptosis. Am J Transplant. 2020;20(6):1606–1618. doi:10.1111/ajt.15773
   PubMed Web of Science ®Google Scholar
• Ye J, Peng J, Liu K, Zhang T, Huang W. MCTR1 inhibits ferroptosis by promoting NRF2 expression to attenuate hepatic ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2022;323(3):G283–G293. doi:10.1152/ajpgi.00354.2021
   Web of Science ®Google Scholar
• Li X, Wu L, Tian X, et al. miR-29a-3p in exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells alleviates steatotic liver ischemia-reperfusion injury in rats by suppressing ferroptosis via iron responsive element binding protein 2. Oxid Med Cell Longev. 2022;2022:6520789. doi:10.1155/2022/6520789
   PubMed Web of Science ®Google Scholar
• Wu Y, Jiao H, Yue Y, et al. Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury. Cell Death Differ. 2022;29(9):1705–1718. doi:10.1038/s41418-022-00957-6
   PubMed Web of Science ®Google Scholar
• Wu S, Yang J, Sun G, et al. Macrophage extracellular traps aggravate iron overload-related liver ischaemia/reperfusion injury. Br J Pharmacol. 2021;178(18):3783–3796. doi:10.1111/bph.15518
   PubMed Web of Science ®Google Scholar
• Wang T-X, Duan K-L, Huang Z-X, et al. Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosis. Life Sci Alliance. 2023;6(1):e202201667. doi:10.26508/lsa.202201667
   Web of Science ®Google Scholar
• Gao H, Jin Z, Bandyopadhyay G, et al. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis. Cell Metab. 2022;34(8):1201–1213.e5. doi:10.1016/j.cmet.2022.07.006
   PubMed Web of Science ®Google Scholar
• Yu Y, Jiang L, Wang H, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood. 2020;136(6):726–739. doi:10.1182/blood.2019002907
   PubMed Web of Science ®Google Scholar
• Yang YM, Noureddin M, Liu C, et al. Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Sci Transl Med. 2019;11:496. doi:10.1126/scitranslmed.aat9284
   Web of Science ®Google Scholar
• Zhang Z, Guo M, Li Y, et al. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy. 2020;16(8):1482–1505. doi:10.1080/15548627.2019.1687985
   PubMed Web of Science ®Google Scholar
• Sui M, Jiang X, Chen J, Yang H, Zhu Y. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway. Biomed Pharmacother. 2018;106:125–133. doi:10.1016/j.biopha.2018.06.060
   PubMed Web of Science ®Google Scholar
• Liu G, Wei C, Yuan S, et al. Wogonoside attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis through SOCS1/P53/SLC7A11 pathway. Phytother Res. 2022;36(11):4230–4243. doi:10.1002/ptr.7558
   Web of Science ®Google Scholar
• Wang L, Zhang Z, Li M, et al. P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. IUBMB Life. 2019;71(1):45–56. doi:10.1002/iub.1895
   PubMed Web of Science ®Google Scholar
• Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280–296. doi:10.1038/s41571-020-00462-0
   PubMed Web of Science ®Google Scholar
• Louandre C, Ezzoukhry Z, Godin C, et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer. 2013;133(7):1732–1742. doi:10.1002/ijc.28159
   PubMed Web of Science ®Google Scholar
• Wang S, Li F, Qiao R, et al. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics. ACS Nano. 2018;12(12):12380–12392. doi:10.1021/acsnano.8b06399
   PubMed Web of Science ®Google Scholar
• Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57–62. doi:10.1038/nature14344
   PubMed Web of Science ®Google Scholar
• Louandre C, Marcq I, Bouhlal H, et al. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells. Cancer Lett. 2015;356(2Pt B):971–977. doi:10.1016/j.canlet.2014.11.014
   PubMed Web of Science ®Google Scholar
• Yuan H, Li X, Zhang X, Kang R, Tang D. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. Biochem Biophys Res Commun. 2016;478(2):838–844. doi:10.1016/j.bbrc.2016.08.034
   PubMed Web of Science ®Google Scholar
• Chen Y, Shang H, Wang C, et al. RNA-seq explores the mechanism of oxygen-boosted sonodynamic therapy based on all-in-one nanobubbles to enhance ferroptosis for the treatment of HCC. Int J Nanomedicine. 2022;17:105–123. doi:10.2147/IJN.S343361
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li M, Yao X, et al. HCAR1/MCT1 regulates tumor ferroptosis through the lactate-mediated AMPK-SCD1 activity and its therapeutic implications. Cell Rep. 2020;33(10):108487. doi:10.1016/j.celrep.2020.108487
   PubMed Web of Science ®Google Scholar
• Liang W, Ferrara N. Iron metabolism in the tumor microenvironment: contributions of innate immune cells. Front Immunol. 2020;11:626812. doi:10.3389/fimmu.2020.626812
   Web of Science ®Google Scholar
• Kim R, Hashimoto A, Markosyan N, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612:338–346. doi:10.1038/s41586-022-05443-0
   PubMed Web of Science ®Google Scholar